Thompson Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.37M | Hold |
|
|||||
|
2025
Q2 | $1.23M | Hold |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $1.21M | Sell |
|
|||||
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $1.09M | Buy |
|
|||||
|
2024
Q1 | $1.05M | Sell |
|
|||||
|
2023
Q4 | $1.01M | Sell |
|
|||||
|
2023
Q3 | $931K | Sell |
|
|||||
|
2023
Q2 | $811K | Buy |
|
|||||
|
2023
Q1 | $833K | Buy |
|
|||||
|
2022
Q4 | $777K | Hold |
|
|||||
|
2022
Q3 | $691K | Sell |
|
|||||
|
2022
Q2 | $761K | Hold |
|
|||||
|
2022
Q1 | $732K | Buy |
|
|||||
|
2021
Q4 | $622K | Buy |
|
|||||
|
2021
Q3 | $665K | Hold |
|
|||||
|
2021
Q2 | $674K | Buy |
|
|||||
|
2021
Q1 | $431K | Hold |
|
|||||
|
2020
Q4 | $425K | Buy |
|
|||||
|
2020
Q3 | $359K | Buy |
|
|||||
|
2020
Q2 | $415K | Buy |
|